TGFB1 and melanoma: Together with our observation that GARP-expressing Tregs are found mostly in human melanoma metastases that are already infiltrated by activated T cells, this led us to suggest testing anti-GARP:TGF-β1 to overcome resistance to PD-1/PD-L1 blockade in patients with inflamed tumors [67].